MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 164 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,088,667 | +50.9% | 153,227 | +43.2% | 0.01% | +57.1% |
| Q3 2022 | $3,373,000 | -13.5% | 106,998 | -16.5% | 0.01% | -12.5% |
| Q2 2022 | $3,900,000 | +437.2% | 128,215 | +358.5% | 0.01% | +700.0% |
| Q1 2022 | $726,000 | -69.3% | 27,962 | -77.9% | 0.00% | -92.3% |
| Q4 2020 | $2,363,000 | +56.4% | 126,430 | +42.1% | 0.01% | +30.0% |
| Q3 2020 | $1,511,000 | +7.5% | 88,947 | -46.9% | 0.01% | -28.6% |
| Q1 2020 | $1,406,000 | -70.8% | 167,361 | -66.0% | 0.01% | -57.6% |
| Q4 2019 | $4,807,000 | +30.8% | 492,034 | +27.1% | 0.03% | +13.8% |
| Q3 2019 | $3,675,000 | -1.1% | 387,199 | +23.8% | 0.03% | -6.5% |
| Q2 2019 | $3,717,000 | +30.1% | 312,886 | +92.7% | 0.03% | +138.5% |
| Q1 2019 | $2,858,000 | -31.2% | 162,330 | -32.2% | 0.01% | -69.0% |
| Q4 2018 | $4,156,000 | +1596.3% | 239,388 | +1801.9% | 0.04% | +2000.0% |
| Q2 2016 | $245,000 | -82.5% | 12,587 | -83.2% | 0.00% | -88.9% |
| Q2 2015 | $1,398,000 | – | 75,021 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |